Cargando…

Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation

Clinical decompensation immediately prior to liver transplantation may affect post-liver transplant (LT) outcomes. Using the serial Model for End-Stage Liver Disease (MELD) scores recorded in the United Network for Organ Sharing national registry (2010–2017), we analyzed post-LT mortality among adul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cholankeril, George, Li, Andrew A., Dennis, Brittany B., Gadiparthi, Chiranjeevi, Kim, Donghee, Toll, Alice E., Maliakkal, Benedict J., Satapathy, Sanjaya K., Nair, Satheesh, Ahmed, Aijaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549161/ https://www.ncbi.nlm.nih.gov/pubmed/31165776 http://dx.doi.org/10.1038/s41598-019-44814-y

Ejemplares similares

Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2018)

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease
por: Dibba, Pratima, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft
por: Liu, Andy, et al.
Publicado: (2018)

The Role of Cannabinoids in the Setting of Cirrhosis
por: Dibba, Pratima, et al.
Publicado: (2018)

Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era
por: Li, Andrew A., et al.
Publicado: (2018)

NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2020)

Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies
por: Snyder, Heather S., et al.
Publicado: (2018)

Underutilization of Living Donor Liver Transplantation in the United States: Bias against MELD 20 and Higher
por: Perumpail, Ryan B., et al.
Publicado: (2016)

Accuracy of Noninvasive Fibrosis Scoring Systems in African American and White Patients With Nonalcoholic Fatty Liver Disease
por: Marella, Hemnishil K., et al.
Publicado: (2020)

Recent advances in liver transplantation with HCV seropositive donors
por: Murag, Soumya, et al.
Publicado: (2019)

Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States
por: Kim, Donghee, et al.
Publicado: (2022)

Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular Mortality
por: Kim, Donghee, et al.
Publicado: (2023)

Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States
por: Kim, Donghee, et al.
Publicado: (2023)

Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management
por: Chauhan, Ranjit, et al.
Publicado: (2018)

Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
por: Nadelson, Jeffrey, et al.
Publicado: (2016)

Liver Transplantation in Patients with Portal Vein Thrombosis: Comparing Pre-MELD and MELD era
por: Saidi, R. F., et al.
Publicado: (2012)

Longitudinal Renal Function in Liver Transplant Recipients With Acute-on-Chronic Liver Failure
por: Yazawa, Masahiko, et al.
Publicado: (2020)

Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
por: Cholankeril, George, et al.
Publicado: (2017)

Outcomes of Liver Transplant Recipients With Acute-on-Chronic Liver Failure Based on EASL-CLIF Consortium Definition: A Single-center Study
por: Agbim, Uchenna, et al.
Publicado: (2020)

MELD-GRAIL and MELD-GRAIL-Na Are Not Superior to MELD or MELD-Na in Predicting Liver Transplant Waiting List Mortality at a Single-center Level
por: Chetwood, John D., et al.
Publicado: (2022)

Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver Transplantation
por: Li, Andrew A., et al.
Publicado: (2018)

Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic
por: Kim, Donghee, et al.
Publicado: (2021)

An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease
por: Perumpail, Brandon J., et al.
Publicado: (2017)

Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis
por: Montano-Loza, Aldo J, et al.
Publicado: (2015)

Rising Rates of Hepatocellular Carcinoma Leading to Liver Transplantation in Baby Boomer Generation with Chronic Hepatitis C, Alcohol Liver Disease, and Nonalcoholic Steatohepatitis-Related Liver Disease
por: Cholankeril, George, et al.
Publicado: (2017)

Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary
por: Dibba, Pratima, et al.
Publicado: (2019)

The Usefulness of Mayo End-stage Liver Disease (MELD) and MELD-Sodium (MELD-Na) Scores for Predicting Mortality in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
por: Coxeter-Smith, Catherine, et al.
Publicado: (2023)

Invited response to “MELD calibration”
por: Goudsmit, Ben F. J., et al.
Publicado: (2020)

MELD-GRAIL-Na Is a Better Predictor of Mortality Than MELD in Korean Patients with Cirrhosis
por: Kim, Jung-Woo, et al.
Publicado: (2023)

HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST
por: NACIF, Lucas Souto, et al.
Publicado: (2018)

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
por: Perumpail, Brandon J, et al.
Publicado: (2017)

MELD-Sarcopenia is Better than ALBI and MELD Score in Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation
por: Alsebaey, Ayman, et al.
Publicado: (2021)

MELD or MELD-Na as a Predictive Model for Mortality Following Transjugular Intrahepatic Portosystemic Shunt Placement
por: Krishnan, Arunkumar, et al.
Publicado: (2023)

MELD: Mixed effects for large datasets
por: Nielson, Dylan M., et al.
Publicado: (2017)

The Melding of Drug Screening Platforms for Melanoma
por: Couto, Gabriela Klein, et al.
Publicado: (2019)

New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years
por: Dennis, Brittany B, et al.
Publicado: (2021)

Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question
por: Pitton, Michael B., et al.
Publicado: (2020)

Modelling kidney outcomes based on MELD eras - impact of MELD score in renal endpoints after liver transplantation
por: Lins, Paulo Ricardo Gessolo, et al.
Publicado: (2022)

Acute Hepatitis A Causing Severe Hemolysis and Renal Failure in Undiagnosed Glucose-6-Phosphate Dehydrogenase Deficient Patient: A Case Report and Review of the Literature
por: Abutineh, Iman, et al.
Publicado: (2021)

Correlation of Model for End Stage Liver Disease (MELD), MELD-Sodium (MELD-Na), and Child-Turcotte-Pugh (CTP) Score With Frailty in Patients With Hepatitis C Virus (HCV) Related Cirrhosis
por: Panezai, Muhammad Qaiser, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hmki6v7jc5bvgtq46oi8o7voav